1217 related articles for article (PubMed ID: 18219369)
1. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages.
O'Mahony DS; Pham U; Iyer R; Hawn TR; Liles WC
Int J Med Sci; 2008 Jan; 5(1):1-8. PubMed ID: 18219369
[TBL] [Abstract][Full Text] [Related]
2. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils.
Kurt-Jones EA; Mandell L; Whitney C; Padgett A; Gosselin K; Newburger PE; Finberg RW
Blood; 2002 Sep; 100(5):1860-8. PubMed ID: 12176910
[TBL] [Abstract][Full Text] [Related]
3. An mRNA atlas of G protein-coupled receptor expression during primary human monocyte/macrophage differentiation and lipopolysaccharide-mediated activation identifies targetable candidate regulators of inflammation.
Hohenhaus DM; Schaale K; Le Cao KA; Seow V; Iyer A; Fairlie DP; Sweet MJ
Immunobiology; 2013 Nov; 218(11):1345-53. PubMed ID: 23948647
[TBL] [Abstract][Full Text] [Related]
4. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 2 and 4 surface expressions on human monocytes are modulated by interferon-gamma and macrophage colony-stimulating factor.
Mita Y; Dobashi K; Shimizu Y; Nakazawa T; Mori M
Immunol Lett; 2001 Sep; 78(2):97-101. PubMed ID: 11672593
[TBL] [Abstract][Full Text] [Related]
6. Priming of neutrophil and monocyte activation in human immunodeficiency virus infection. Comparison of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and interferon-gamma.
Meyer CN; Nielsen H
APMIS; 1996 Sep; 104(9):640-6. PubMed ID: 8972688
[TBL] [Abstract][Full Text] [Related]
7. GM-CSF Down-Regulates TLR Expression via the Transcription Factor PU.1 in Human Monocytes.
Sadeghi K; Wisgrill L; Wessely I; Diesner SC; Schüller S; Dürr C; Heinle A; Sachet M; Pollak A; Förster-Waldl E; Spittler A
PLoS One; 2016; 11(10):e0162667. PubMed ID: 27695085
[TBL] [Abstract][Full Text] [Related]
8. Porphyromonas gulae Activates Unprimed and Gamma Interferon-Primed Macrophages via the Pattern Recognition Receptors Toll-Like Receptor 2 (TLR2), TLR4, and NOD2.
Holden JA; O'Brien-Simpson NM; Lenzo JC; Orth RKH; Mansell A; Reynolds EC
Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28630066
[No Abstract] [Full Text] [Related]
9. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.
Sirén J; Pirhonen J; Julkunen I; Matikainen S
J Immunol; 2005 Feb; 174(4):1932-7. PubMed ID: 15699120
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory approaches to augment phagocyte-mediated host defense for treatment of infectious diseases.
Liles WC
Semin Respir Infect; 2001 Mar; 16(1):11-7. PubMed ID: 11309708
[TBL] [Abstract][Full Text] [Related]
11. Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages.
Sweet MJ; Campbell CC; Sester DP; Xu D; McDonald RC; Stacey KJ; Hume DA; Liew FY
J Immunol; 2002 Jan; 168(1):392-9. PubMed ID: 11751985
[TBL] [Abstract][Full Text] [Related]
12. GM-CSF priming drives bone marrow-derived macrophages to a pro-inflammatory pattern and downmodulates PGE2 in response to TLR2 ligands.
Sorgi CA; Rose S; Court N; Carlos D; Paula-Silva FW; Assis PA; Frantz FG; Ryffel B; Quesniaux V; Faccioli LH
PLoS One; 2012; 7(7):e40523. PubMed ID: 22808181
[TBL] [Abstract][Full Text] [Related]
13. Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression.
Adib-Conquy M; Cavaillon JM
J Biol Chem; 2002 Aug; 277(31):27927-34. PubMed ID: 12032143
[TBL] [Abstract][Full Text] [Related]
14. Synergism of glucocorticoids with granulocyte macrophage colony stimulating factor (GM-CSF) but not interferon gamma (IFN-gamma) or interleukin-4 (IL-4) on induction of HLA class II expression on human monocytes.
Sadeghi R; Hawrylowicz CM; Chernajovsky Y; Feldmann M
Cytokine; 1992 Jul; 4(4):287-97. PubMed ID: 1515553
[TBL] [Abstract][Full Text] [Related]
15. The meningococcal adhesin NhhA provokes proinflammatory responses in macrophages via toll-like receptor 4-dependent and -independent pathways.
Sjölinder M; Altenbacher G; Wang X; Gao Y; Hansson C; Sjölinder H
Infect Immun; 2012 Nov; 80(11):4027-33. PubMed ID: 22949555
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors stimulate human neutrophil function.
Hayashi F; Means TK; Luster AD
Blood; 2003 Oct; 102(7):2660-9. PubMed ID: 12829592
[TBL] [Abstract][Full Text] [Related]
17. Activated phenotype in neutrophils and monocytes from patients with primary proliferative polycythaemia.
Westwood NB; Copson ER; Page LA; Mire-Sluis AR; Brown KA; Pearson TC
J Clin Pathol; 1995 Jun; 48(6):525-30. PubMed ID: 7545186
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
Hübel K; Dale DC; Liles WC
J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte toll-like receptor expression in end-stage kidney disease.
Gollapudi P; Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
Am J Nephrol; 2010; 31(3):247-54. PubMed ID: 20090311
[TBL] [Abstract][Full Text] [Related]
20. Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9.
Hölscher C; Reiling N; Schaible UE; Hölscher A; Bathmann C; Korbel D; Lenz I; Sonntag T; Kröger S; Akira S; Mossmann H; Kirschning CJ; Wagner H; Freudenberg M; Ehlers S
Eur J Immunol; 2008 Mar; 38(3):680-94. PubMed ID: 18266299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
